Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

ABVC — ABVC BioPharma, Inc. Dilution Risk Tracker

Track ABVC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ABVC — Get alerts when the score changes →

As of August 28, 2026, ABVC BioPharma, Inc. (ABVC) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. ABVC BioPharma, Inc. has a market capitalization of $36.66M, 26.65M shares outstanding, 15 institutional holders tracked. Stored dilution-related fields include 500.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
35

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 44%
💰 Capital Raise model 55%
• Critical: only 0.3 months cash remaining
🔄 Reverse Split model est. 45%
• 50-day avg $1.17 approaching $1 threshold
• Only 0 months cash — financial pressure
🔁 Convertible Conversion model 15%
• Convertible debt present: 5.9% potential dilution
🔔 Track ABVC — Get forecast alerts →

Market Data

Market Cap$36.66M
Shares Outstanding26.65M
Float20.44M
Cash$94.4K
Debt$183.9K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 16.7% shares (2026Q1 vs prior)
15 institutional holders · 1.02M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 381.1K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 221.2K shares
#3 VANGUARD FIDUCIARY TRUST CO 97.4K shares
+ 12 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest441.8K
Days to Cover5.6
% of Float2.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2025-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ABVC Dilution Snapshot

ABVC BioPharma, Inc. (ABVC) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ABVC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ABVC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ABVC
ABVC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.